Skip to main content

ADM

Stock
Consumer Staples
Farm Products

Performance overview

ADM Price
Price Chart

Forward-looking statistics

Beta
0.68
Risk
28.19%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.

Company info

SectorConsumer Staples
IndustryFarm Products
Employees34K
Market cap$30.3B

Fundamentals

Enterprise value$37.1B
Revenue$83.9B
Revenue per employee
Profit margin1.63%
Debt to equity55.50

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$2.84
Dividend per share$2.04
Revenue per share$173.08
Avg trading volume (30 day)$209M
Avg trading volume (10 day)$249M
Put-call ratio

Macro factor sensitivity

Growth+1.4
Credit+2.7
Liquidity-0.1
Inflation-0.4
Commodities-0.2
Interest Rates-0.5

Valuation

Dividend yield3.69%
PEG Ratio10.91
Price to sales0.32
P/E Ratio10.91
Enterprise Value to Revenue0.44
Price to book1.20

Upcoming events

Next earnings dayMay 6, 2025
Next dividend day
Ex. dividend dayMay 21, 2025

News

Adma Biologics (ADMA) Outperforms Broader Market: What You Need to Know

Adma Biologics (ADMA) concluded the recent trading session at $18.34, signifying a +2.98% move from its prior day's close.

Zacks Investment Research (July 9, 2025)
Archer Daniels Midland (ADM) Stock Drops Despite Market Gains: Important Facts to Note

In the closing of the recent trading day, Archer Daniels Midland (ADM) stood at $55.31, denoting a -1.06% move from the preceding trading day.

Zacks Investment Research (July 3, 2025)
4 Agriculture Operations Stocks Riding Health Trends Amid Margin Woes

The Agriculture - Operations industry is gaining from healthy eating trends, innovation and global demand, but rising costs and trade risks pose challenges. CTVA, ADM, AVO and ALCO look promising.

Zacks Investment Research (July 3, 2025)
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?

ADMA's surging Asceniv demand and bold revenue forecasts set it apart in the competitive plasma therapies space.

Zacks Investment Research (June 25, 2025)
3 Stocks To Turn Tariffs Into Opportunities

Editor's Note: Today , we're hearing from Tom Gentile, one of America's most successful pattern traders, with 30 years of trading and teaching experience  under his belt. You may recognize him from Money Morning, CNBC, or the numerous options books he has authored.

Benzinga (April 30, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free